alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Postal Service

# AGENCY:

                        Postal ServiceTM.                    

# ACTION:

Notice.

# SUMMARY:

The Postal Service gives notice of filing a request with the Postal Regulatory Commission to add a domestic shipping services contract to the list of Negotiated Service Agreements in the Mail Classification Schedule's Competitive Products List.

# DATES:

*Date of required notice:*                         November 29, 2024.                    

# FOR FURTHER INFORMATION CONTACT:

Sean C. Robinson, 202-268-8405.

# SUPPLEMENTARY INFORMATION:

                    The United States Postal Service® hereby gives notice that, pursuant to 39 U.S.C. 3642 and 3632(b)(3), on November 22, 2024, it filed with the Postal Regulatory Commission a                     *USPS Request to Add Priority Mail Express, Priority Mail & USPS Ground Advantage® Contract 782 to Competitive Product List.*                     Documents are available at                     *www.prc.gov,*                     Docket Nos. MC2025-484, K2025-481.                

Sean C. Robinson,

Attorney, Corporate and Postal Business Law.

[FR Doc. 2024-27958 Filed 11-27-24; 8:45 am]

BILLING CODE 7710-12-P
```

[Congressional Bills 115th Congress]
[From the U.S. Government Publishing Office]
[H.R. 1850 Received in Senate (RDS)]

<DOC>
115th CONGRESS
  2d Session
                                H. R. 1850

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                           December 12, 2018

                                Received

_______________________________________________________________________

                                 AN ACT

 
 To designate the facility of the United States Postal Service located 
 at 907 Fourth Avenue in Lake Odessa, Michigan, as the ``Donna Sauers 
                          Besko Post Office''.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. DONNA SAUERS BESKO POST OFFICE.

    (a) Designation.--The facility of the United States Postal Service 
located at 907 Fourth Avenue in Lake Odessa, Michigan, shall be known 
and designated as the ``Donna Sauers Besko Post Office''.
    (b) References.--Any reference in a law, map, regulation, document, 
paper, or other record of the United States to the facility referred to 
in subsection (a) shall be deemed to be a reference to the ``Donna 
Sauers Besko Post Office''.

            Passed the House of Representatives December 11, 2018.

            Attest:

                                                 KAREN L. HAAS,

                                                                 Clerk.
```
---

EXHIBIT 13.1  CERTIFICATION OF CEO AND CFO

|CERTIFICATION                                            
|---------------------------------------------------------
|PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
|(SUBSECTIONS (a) AND (b) OF SECTION 1350, CHAPTER 63 OF  
|TITLE 18, UNITED STATES CODE)                            

Pursuant to section 906 of the Sarbanes-Oxley Act of 2002
(subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States
Code), each of the undersigned officers of Medicure Inc. (the "Company"), does
hereby certify with respect to the Annual Report of the Company on Form 20-F for
the year ended May 31, 2010 as filed with the Securities and Exchange Commission
on the date hereof (the "Form 20-F") that, to the best of their knowledge:

(1) the Form 20-F fully complies
with the requirements of section 13(a) or 15(d) of the Securities Exchange Act
of 1934; and

(2) the information contained in
the Form 20-F fairly presents, in all material respects, the financial condition
and results of operations of the Company.

|Date: September 28, 2010 | /s/ Albert Friesen                            
|------------------------ | ----------------------------------------------
|                         |                                               
|                         | Albert D. Friesen, Chief Executive Officer    
|                         | (Principal Executive Officer)                 
|                         |                                               
|                         |                                               
|Date: September 28, 2010 | /s/ Eric Johnstone                            
|                         |                                               
|                         | Eric R. Johnstone, CA, Chief Financial Officer
|                         | (Principal Financial Officer)                 

A signed original of this written statement required by Section
906, or other document authenticating, acknowledging, or otherwise adopting the
signature that appears in typed form within the electronic version of this
written statement required by Section 906, has been provided to the Company and
will be retained by the Company and furnished to the Securities and Exchange
Commission or its staff upon request.

---
**Exhibit 99.2**

 

**CERTIFICATION PURSUANT TO**

**18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO**

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

 

In connection with the quarterly report of Pharmaceutical Product Development, Inc. (“PPD”) on Form 10-Q for the period ended March 31, 2003 asfiled with the Securities and Exchange Commission on the date hereof (the “Report”), I, Linda Baddour, Chief Financial Officer of PPD, hereby certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of theSarbanes-Oxley Act of 2002, that to my knowledge: 

 

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Act of 1934; and 

 

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations ofPPD as of, and for, the periods presented in the Report. 

 

Date: May 9, 2003
#### The People of the State of New York, Respondent, v Anonymous, Appellant.

[631 NYS2d 673]

Judgment, Supreme Court, New York County (Renee White, J.), rendered April 20, 1993, convicting defendant, upon his plea of guilty, of robbery in the first degree, and sentencing him, as a second felony offender, to a term of 121/2 to 25 years, unanimously affirmed.

Defendant’s sentence to the maximum term was in accordance with his plea bargain, under which the People were to recommend whatever sentence they deemed warranted by defendant’s cooperation, subject, of course, to the court’s ultimate sentencing discretion *(see People v Garcia,*163 AD2d *526218, *lv denied*77 NY2d 838; *People v Farrar,*52 NY2d 302, 305-306), which, we find, it properly exercised. Defendant’s cooperation, while apparently sincere, resulted in no indictments, and the People recommended the maximum sentence. While indictments were not a condition for a recommendation of leniency, neither was it agreed that such a recommendation would be made in exchange for simple cooperation. Defendant was never promised a term less than the maximum, and, as the sentencing court stated, was given "appropriate leniency” by virtue of the fact that the sentence he received was less than the life imprisonment he faced on the charges of the indictment. Concur — Rosenberger, J. P., Rubin, Asch, Williams and Mazzarelli, JJ.
```

[Congressional Bills 115th Congress]
[From the U.S. Government Publishing Office]
[H.R. 1786 Introduced in House (IH)]

<DOC>

115th CONGRESS
  1st Session
                                H. R. 1786

To reduce the rate of pay for Members of Congress by 10 percent and to 
            eliminate automatic pay adjustments for Members.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                             March 29, 2017

 Mr. Loebsack introduced the following bill; which was referred to the 
Committee on House Administration, and in addition to the Committee on 
   Oversight and Government Reform, for a period to be subsequently 
   determined by the Speaker, in each case for consideration of such 
 provisions as fall within the jurisdiction of the committee concerned

_______________________________________________________________________

                                 A BILL

 
To reduce the rate of pay for Members of Congress by 10 percent and to 
            eliminate automatic pay adjustments for Members.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Congressional Halt in Pay Increases 
and Cut Congressional Pay Act''.

SEC. 2. REDUCTION IN PAY.

    (a) In General.--Section 601(a) of the Legislative Reorganization 
Act of 1946 (2 U.S.C. 4501) is amended to read as follows:
    ``Sec. 601. (a) Effective as of the beginning of the first 
applicable pay period commencing after the date on which is held the 
next regularly scheduled general election for Federal office following 
the date of the enactment of the Congressional Halt in Pay Increases 
and Cut Congressional Pay Act, the annual rate of pay for--
            ``(1) each Senator, Member of the House of Representatives, 
        and Delegate to the House of Representatives, and the Resident 
        Commissioner from Puerto Rico,
            ``(2) the President pro tempore of the Senate, the majority 
        leader and the minority leader of the Senate, and the majority 
        leader and the minority leader of the House of Representatives, 
        and
            ``(3) the Speaker of the House of Representatives,
shall be equal to the annual rate of pay for that position as of the 
date on which such general election is held, reduced by 10 percent.''.
    (b) Effective Date.--Subsection (a) shall take effect as of the 
date on which is held the next regularly scheduled general election for 
Federal office following the date of the enactment of this Act.
                                 <all>
```
<PAGE>   1



                                                                    EXHIBIT 11.1

                       CALCULATION OF EARNINGS PER SHARE
         FOR THE THREE MONTHS AND NINE MONTHS ENDED SEPTEMBER 30, 1996

<TABLE>
<CAPTION>
-------------------------------------------------------------------------------------------------------------------
                                                THREE MONTHS      THREE MONTHS       NINE MONTHS       NINE MONTHS
                                                    ENDED             ENDED             ENDED             ENDED
                                               SEPT. 30, 1996    SEPT. 30, 1995    SEPT. 30, 1996    SEPT. 30, 1995
-------------------------------------------------------------------------------------------------------------------
<S>                                             <C>                  <C>             <C>               <C>
Net income . . . . . . . . . . . . . . . . . .  $1,395,676           $483,932        $ 3,965,342       $ 1,972,503
                                                ==========           ========         ==========       ===========
                       
Common and common equivalent shares:
      Weighted average number of
      common shares outstanding
      during the period . . . . . . . . . . . .  5,504,280          3,273,298          5,463,983         3,238,482

      Common shares issuable upon
          conversion of convertible
          preferred stock
               Primary . . . . . . . . . . . .          --            958,721                              958,721
               Fully diluted  . . . . . . . . .         --            958,721                              958,721

      Common shares issuable upon exercise
          of outstanding stock options
               Primary . . . . . . . . . . . .     435,786            236,588            437,592           168,502
               Fully diluted . . . . . . . . .     438,985            236,588            455,596           168,502

      Common and common equivalent shares
          outstanding during the period
               Primary . . . . . . . . . . . .   5,940,066          4,468,607          5,901,575         4,365,705
                                                 =========          =========          =========         =========
               Fully diluted . . . . . . . . .   5,943,265          4,468,607          5,919,579         4,365,705
                                                 =========          =========          =========         =========
Earnings per share data
      Net income per common and common
          equivalent shares
               Primary . . . . . . . . . . . .    $   0.23           $   0.11           $   0.67          $   0.45
               Fully diluted . . . . . . . . .    $   0.23           $   0.11           $   0.67          $   0.45
</TABLE>

                                       21
Exhibit 31.1

            PRINCIPAL EXECUTIVE OFFICER CERTIFICATION

I, John W. Peters, certify that:

1.  I have reviewed this annual report on Form 10-KSB of Cancer Capital Corp.;

2.  Based on my knowledge, this annual report does not contain any untrue
statement of a material fact or omit to state a material fact necessary to
make the statement made, in light of the circumstances under which statements
were made, not misleading with respect to the period covered by this annual
report;

3.  Based on my knowledge, the financial statements, and other financial
information included in this report, fairly present in all material respects
the financial condition, results of operations and cash flows of the small
business issuer as of, and for, the periods presented in this report.

4.  The small business issuer's other certifying officer(s) and I are
responsible for establishing and maintaining disclosure controls and
procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the
small business issuer and have:

    (a) Designed such disclosure controls and procedures, or caused such
disclosure controls and procedures to be designed under our supervision, to
ensure that material information relating to the small business issuer,
including its consolidated subsidiaries, is made known to us by others within
those entities, particularly during the period in which this report is being
prepared;

    (b) Evaluated the effectiveness of the small business issuer's disclosure
controls and procedures and presented in this report our conclusions about the
effectiveness of the disclosure controls and procedures, as of the end of the
period covered by this report based on such evaluation; and

    (c) Disclosed in this report any change in the small business issuer's
internal control over financial reporting that occurred during the small
business issuer's most recent fiscal quarter (the small business issuer's
fourth fiscal quarter in the case of an annual report) that has materially
affected, or is reasonably likely to materially affect, the small business
issuers's internal control over financial reporting; and

5.  The small business issuer's other certifying officer(s) and I have
disclosed, based on our most recent evaluation of internal control over
financial reporting, to the small business issuer's auditors and the audit
committee of small business issuer's board of directors (or persons performing
the equivalent function):

    (a) All significant deficiencies and material weaknesses in the design or
operation of internal control over financial reporting which are reasonably
likely to adversely affect the small business issuer's ability to record,
process, summarize and report financial information; and

    (b) Any fraud, whether or not material, that involves management or other
employees who have a significant role in the small business issuer's internal
control over financial reporting.

                                  /s/ John W. Peters
Date: March 12, 2004              ____________________________________
                                  John W. Peters
                                  Principal Executive Officer
<TABLE> <S> <C>

<PAGE>

<ARTICLE> 5
<MULTIPLIER> 1,000

<S>                             <C>                      <C>
<PERIOD-TYPE>                   3-MOS                    6-MOS
<FISCAL-YEAR-END>                         DEC-31-1999              DEC-31-1999
<PERIOD-START>                            APR-01-1999              JAN-01-1999
<PERIOD-END>                              JUN-30-1999              JUN-01-1999
<CASH>                                          7,793                        0
<SECURITIES>                                        0                        0
<RECEIVABLES>                                   7,571                        0
<ALLOWANCES>                                        0                        0
<INVENTORY>                                         0                        0
<CURRENT-ASSETS>                               50,043                        0
<PP&E>                                      1,855,511                        0
<DEPRECIATION>                                100,456                        0
<TOTAL-ASSETS>                              1,823,003                        0
<CURRENT-LIABILITIES>                          80,988                        0
<BONDS>                                       788,000                        0
<PREFERRED-MANDATORY>                               0                        0
<PREFERRED>                                         0                        0
<COMMON>                                          965                        0
<OTHER-SE>                                    892,974                        0
<TOTAL-LIABILITY-AND-EQUITY>                1,823,003                        0
<SALES>                                             0                        0
<TOTAL-REVENUES>                              106,487                  195,906
<CGS>                                               0                        0
<TOTAL-COSTS>                                  44,053                   85,046
<OTHER-EXPENSES>                               24,272                   48,494
<LOSS-PROVISION>                                    0                        0
<INTEREST-EXPENSE>                             13,817                   25,268
<INCOME-PRETAX>                                24,345                   37,098
<INCOME-TAX>                                    9,739                   14,840
<INCOME-CONTINUING>                            14,606                   22,258
<DISCONTINUED>                                      0                        0
<EXTRAORDINARY>                                     0                        0
<CHANGES>                                           0                      779
<NET-INCOME>                                   14,606                   21,479
<EPS-BASIC>                                      0.15                     0.22
<EPS-DILUTED>                                    0.15                     0.22


</TABLE>
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
CONSOLIDATED INCOME STATEMENTS, THE CONSOLIDATED BALANCE SHEETS AND THE
ACCOMPANYING NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS, AND IS QUALIFIED
IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1998
<PERIOD-START>                             JAN-01-1998
<PERIOD-END>                               SEP-30-1998
<CASH>                                           5,560
<SECURITIES>                                    10,857
<RECEIVABLES>                                   13,357
<ALLOWANCES>                                         0
<INVENTORY>                                      6,811
<CURRENT-ASSETS>                                38,378
<PP&E>                                          12,073
<DEPRECIATION>                                   6,550
<TOTAL-ASSETS>                                  43,901
<CURRENT-LIABILITIES>                            9,068
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                            10
<OTHER-SE>                                      34,823
<TOTAL-LIABILITY-AND-EQUITY>                    43,901
<SALES>                                         22,230
<TOTAL-REVENUES>                                30,089
<CGS>                                           12,750
<TOTAL-COSTS>                                   12,750
<OTHER-EXPENSES>                                 9,654
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                     70
<INCOME-TAX>                                        14
<INCOME-CONTINUING>                                 56
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                        56
<EPS-PRIMARY>                                     0.01
<EPS-DILUTED>                                     0.01
        

</TABLE>